OriGene Technologies, Inc.
Search:    
Left ProductsProducts divider ServicesServices divider technologyTechnology divider researchResearch divider TechsupportTechSupport divider AboutAbout Right
 
Home Antibody All anti-MYBL2 antibodies

Anti-MYBL2 PHOSPHO Antibody EPR2204Y

div

Specifications Citations Related Products Product Documents
SKU Description Amount Price Availability*  
TA301225
  • Rabbit Monoclonal Antibody against MYBL2 (Clone EPR2204Y) (Phospho-specific)
100ul 325 3-7 Days
Add to Shopping Cart
WB(1)
IHC(1)
IF(1)
FC(1)
spacer
Also for MYBL2 (NM_002466)
cDNA Clone shRNA/siRNA Lysate Protein Antibody

OriGene Data

ImmunogenA phospho specific peptide corresponding to residues surrounding threonine 487 of human B-Myb was used as an immunogen. This antibody detects B-Myb phosphorlyated on threonine 487.
Clone NameEPR2204Y IsotypeIgG
Species ReactivityMouse, Rat, Human ConcentrationLot dependent; please refer to CoA along with shipment
Guaranteed Application *WB, IHC, IF, FC Suggested DilutionsChIP: Use at an assay dependent concentration; ICC/IF: 1:100 - 1:250; FC: 1:50; WB: 1:500 - 1:1000; IP: 1:40; IHC-P: 1:100 - 1:250
BufferPBS 49%,Sodium azide 0.01%,Glycerol 50%,BSA 0.05%
Purification Tissue culture supernatant

Reference Data

Target NameHomo sapiens v-myb avian myeloblastosis viral oncogene homolog-like 2 (MYBL2), transcript variant 1
Alternative NameB-MYB; BMYB
Database LinkNP_002457
Entrez Gene 4605 Human
Entrez Gene 17865 Mouse
Entrez Gene 296344 Rat
FunctionExpression of the B-Myb transcription factor is upregulated during late G1 phase of the cell cycle by an E2F-dependent transcriptional mechanism. B-Myb is specifically phosphorylated during S phase, suggesting that a cyclin-dependent kinase (Cdk) regulates its activity. Consistent with this notion, the S phase-specific cyclin A/Cdk2 was found previously to enhance B-Myb transactivation activity in cotransfected cells. There is evidence that B-Myb is a direct physiological target for cyclin A/Cdk2. Data indicate that phosphorylation by cyclin A/Cdk2 is directly involved in enhancing B-Myb transactivation activity and that levels of endogenous cyclin A/Cdk2 activity may contribute to cell line-specific B-Myb function (1). Nuclear entry of B-Myb is dependent on multiple nuclear localization signals (NLS's). Mutagenesis of the putative NLS's of B-Myb has identified two separate NLS's, NLS1 and NLS2. Each of the two NLS's is essential for efficient nuclear targeting (2).
Related Pathway

* Availability is in business days
* OriGene provides validated application data and protocol, with money back guarantee.

WB Image
Western blot - B MyB (phospho T487) antibody [EPR2204Y]; All lanes : Anti-B MyB (phospho T487) antibody [EPR2204Y] - ChIP Grade at 1/1000 dilution.Lane 1 : Raji cell lysate, untreated.Lane 2 : Raji cell lysate treated with TPA + IGF.Lysates/proteins at 10 ug per lane.Secondary.Goat anti-rabbit HRP at 1/1000 dilution.Predicted band size : 79 kDa.Observed band size : 110 kDa .
IHC Image
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - B MyB (phospho T487) antibody [EPR2204Y]; TA301225, at 1/100 dilution, staining B MyB in human urinary bladder carcinoma by immunohistochemistry using paraffin-embedded tissue.
IF Image
Immunocytochemistry/ Immunofluorescence - B MyB (phospho T487) antibody [EPR2204Y]; TA301225, at 1/100 dilution, staining B MyB in HeLa cells by immunofluorescence.
FC Image
Flow Cytometry-Anti-B MyB (phospho T487) antibody [EPR2204Y](TA301225); Overlay histogram showing HeLa cells stained with TA301225 (red line). The cells were fixed with 4% paraformaldehyde (10 min) and then permeabilized with 0.1% PBS-Tween for 20 min. The cells were then incubated in 1x PBS / 10% normal goat serum / 0.3M glycine to block non-specific protein-protein interactions followed by the antibody for 30 min at 22°C. The secondary antibody used was DyLight 488 goat anti-rabbit IgG (H+L) at 1/500 dilution for 30 min at 22°C. Isotype control antibody (black line) was rabbit IgG (monclonal) (1ug/1x10^6 cells) used under the same conditions. Acquisition of >5,000 events was performed. This antibody gave a positive signal in HeLa cells fixed with 80% methanol (5 min)/permeabilized with 0.1% PBS-Tween for 20 min used under the same conditions.

 

spacer
Inc 5000 Healthcare Company Copyright © 2014 OriGene Technologies, Inc. All Rights Reserved. Legal Notices.
9620 Medical Center Dr., Suite 200, Rockville, MD 20850 • 1.888.267.4436

Reproduction of any materials from this website is strictly forbidden without permission.

All Products by: Title | Price | Category | Popularity | Best Sellers Topselling Products by: Title | Price | Category | Popularity | Favorites
Popular Categories: Popularity | Our Choices | All-Round Favorites | Title Topselling Categories: Popularity | Our Choices | All-Round Favorites | Title